GRAFT VERSUS HOST DISEASE side effect
What is GRAFT VERSUS HOST DISEASE ?Drugs associated with GRAFT VERSUS HOST DISEASE
ALDURAZYME ALEMTUZUMAB ANTINEOPLASTIC BUSULFAN CAMPATH CANCIDAS CASPOFUNGIN CIPRO CUBICIN CYCLOPHOSPHAMIDE CYCLOSPORINE CYTARABINE DAUNORUBICIN DEXAMETHASONE ETOPOSIDE EXJADE FLUDARA FLUDARABINE IMURAN INTERFERON ITRACONAZOLE MAB MABTHERA METHOTREXATE MINIMS PENTOSTATIN PREDNISOLONE PREDNISONE PROGRAF REVLIMID RITUXIMAB SANDIMMUNE THYMOGLOBULIN VALTREX VELCADEGRAFT VERSUS HOST DISEASE : Mab Side Effects Report #5657043-X
Consumer or non-health professional from MEXICO reported MAB CAMPATH problem on Feb 18, 2008. Male patient, 33 years of age, was diagnosed with graft versus host disease, antifungal prophylaxis, antiviral prophylaxis, prophylaxis against graft versus host disease and was treated with MAB CAMPATH. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . MAB CAMPATH dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, FLUCONAZOLE, ACYCLOVIR, ITRACONAZOLE, METHOTREXATE. Patient died.
GRAFT VERSUS HOST DISEASE : Mab Side Effects Report #5657075-1
MAB CAMPATH problem was reported by a Consumer or non-health professional from MEXICO on Feb 19, 2008. Male patient, 53 years of age, was diagnosed with acute graft versus host disease, pneumocystis jiroveci infection, antifungal prophylaxis, antiviral prophylaxis and was treated with MAB CAMPATH. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . MAB CAMPATH dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, FLUCONAZOLE, ACYCLOVIR. Patient died.
GRAFT VERSUS HOST DISEASE : Mab Side Effects Report #5661796-4
Consumer or non-health professional from MEXICO reported MAB CAMPATH problem on Feb 19, 2008. Male patient, 53 years of age, was diagnosed with acute graft versus host disease, pneumocystis jiroveci infection, antifungal prophylaxis, antiviral prophylaxis and was treated with MAB CAMPATH. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . MAB CAMPATH dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, FLUCONAZOLE, ACYCLOVIR. Patient died.
GRAFT VERSUS HOST DISEASE : Prednisone Side Effects Report #5678666-8
PREDNISONE problem was reported by a Health Professional from CANADA on Mar 10, 2008. Female patient, 44 years of age, weighting 215.6 lb, was diagnosed with infection prophylaxis and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, herpes simplex, lobar pneumonia, mucosal inflammation, . PREDNISONE dosage: unknown. During the same period patient was treated with VORICONAZOLE, MYCOPHENOLATE MOFETIL, TACROLIMUS, RABEPRAZOLE, ACYCLOVIR, NIFEDIPINE, MAGNESIUM, RESTAS. Patient was hospitalized. Patient recovered.
GRAFT VERSUS HOST DISEASE : Busulfan Side Effects Report #5679929-2
Consumer or non-health professional from CANADA reported BUSULFAN problem on Mar 13, 2008. Female patient was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . BUSULFAN dosage: 3.2 MG/KG; X1; IV. During the same period patient was treated with FLUDARABINE. Patient died.
GRAFT VERSUS HOST DISEASE : Busulfan Side Effects Report #5679930-9
BUSULFAN problem was reported by a Consumer or non-health professional from CANADA on Mar 13, 2008. Female patient was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . BUSULFAN dosage: 3.2 MG/KG; X1; IV. During the same period patient was treated with FLUDARABINE. Patient died.
GRAFT VERSUS HOST DISEASE : Alemtuzumab Side Effects Report #5627853-3
Health Professional from MEXICO reported ALEMTUZUMAB problem on Feb 05, 2008. Male patient, 33 years of age, was diagnosed with graft versus host disease, stem cell transplant, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARA, CYCLOSPORINE, CORTICOSTEROIDS, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
GRAFT VERSUS HOST DISEASE : Alemtuzumab Side Effects Report #5629376-4
ALEMTUZUMAB problem was reported by a Health Professional from MEXICO on Feb 05, 2008. Male patient, 53 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, SULFAMETHOXAZOLE, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
GRAFT VERSUS HOST DISEASE : Alemtuzumab Side Effects Report #5629378-8
Health Professional from MEXICO reported ALEMTUZUMAB problem on Feb 05, 2008. Female patient, 27 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5630523-9
FLUDARABINE problem was reported by a Health Professional from CANADA on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Alemtuzumab Side Effects Report #5631876-8
Health Professional from MEXICO reported ALEMTUZUMAB problem on Feb 05, 2008. Male patient, 53 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, SULFAMETHOXAZOLE, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
GRAFT VERSUS HOST DISEASE : Alemtuzumab Side Effects Report #5631877-X
ALEMTUZUMAB problem was reported by a Health Professional from MEXICO on Feb 05, 2008. Female patient, 27 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5632875-2
Consumer or non-health professional from GERMANY reported FLUDARABINE problem on Feb 07, 2008. Female patient was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, ATGAM, CYCLOSPORINE. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5633036-3
FLUDARABINE problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2008. Female patient was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, ATGAM, CYCLOSPORINE. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5633299-4
Health Professional from CANADA reported FLUDARABINE problem on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5633312-4
FLUDARABINE problem was reported by a Health Professional from CANADA on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5633313-6
Health Professional from CANADA reported FLUDARABINE problem on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5633315-X
FLUDARABINE problem was reported by a Health Professional from CANADA on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5633316-1
Health Professional from CANADA reported FLUDARABINE problem on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5633354-9
FLUDARABINE problem was reported by a Health Professional from CANADA on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5633355-0
Health Professional from CANADA reported FLUDARABINE problem on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5633356-2
FLUDARABINE problem was reported by a Health Professional from CANADA on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5635348-6
Health Professional from CANADA reported FLUDARABINE problem on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5635350-4
FLUDARABINE problem was reported by a Health Professional from CANADA on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Fludarabine Side Effects Report #5635370-X
Health Professional from CANADA reported FLUDARABINE problem on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
GRAFT VERSUS HOST DISEASE : Rituximab Side Effects Report #5593996-6
RITUXIMAB problem was reported by a Physician from FRANCE on Jan 16, 2008. Male patient was diagnosed with chronic lymphocytic leukaemia, infection, cytomegalovirus infection and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . RITUXIMAB dosage: 375 MG, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, AMIKLIN, CYMEVAN. Patient was hospitalized. Patient recovered.
GRAFT VERSUS HOST DISEASE : Cipro Side Effects Report #5595470-X
Health Professional from UNITED STATES reported CIPRO problem on Jan 16, 2008. Male patient was treated with CIPRO. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . CIPRO dosage: unknown. Patient died on 12/03/2007.
GRAFT VERSUS HOST DISEASE : Revlimid Side Effects Report #5628265-9
REVLIMID problem was reported by a Health Professional from UNITED STATES on Nov 20, 2007. Male patient, 57 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient recovered.
GRAFT VERSUS HOST DISEASE : Prograf Side Effects Report #5542809-7
Physician from UNITED STATES reported PROGRAF problem on Nov 27, 2007. Male patient, 36 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, MYCOPHENOLATE MOFETIL, HYDROXYCHLOROQUINE SULPHATE. Patient recovered.
GRAFT VERSUS HOST DISEASE : Cyclosporine Side Effects Report #5549520-7
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Dec 05, 2007. Female patient, 57 years of age, was diagnosed with renal transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, kidney transplant rejection, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with SIMULECT, MIZORIBINE, PREDNISOLONE. Patient recovered.
GRAFT VERSUS HOST DISEASE : Cyclosporine Side Effects Report #5550505-5
Physician from UNITED STATES reported CYCLOSPORINE problem on Nov 26, 2007. Male patient, 67 years of age, was diagnosed with liver transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, kaposi's sarcoma, meningitis, nosocomial infection, pneumonia, pseudomembranous colitis, respiratory failure, sepsis, . CYCLOSPORINE dosage: unknown. Patient was hospitalized. Patient died.
GRAFT VERSUS HOST DISEASE : Cyclophosphamide Side Effects Report #5554439-1
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from GREECE on Dec 10, 2007. Female patient, 28 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, hormone level abnormal, ovarian failure, uterine haemorrhage, vaginal disorder, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, CYCLOSPORINE. Patient recovered.
GRAFT VERSUS HOST DISEASE : Imuran Side Effects Report #5574384-5
Health Professional from UNITED STATES reported IMURAN problem on Dec 11, 2007. Male patient, child 11 years of age, weighting 75.00 lb, was diagnosed with immunosuppression, growth hormone deficiency and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, squamous cell carcinoma, . IMURAN dosage: 50 MG;QOD;PO. During the same period patient was treated with PROGRAF, SAIZEN, VFEND, ACYCLOVIR, CORTEF, LEVAQUIN, PREDNISONE. Patient recovered.
GRAFT VERSUS HOST DISEASE : Prograf Side Effects Report #5509953-1
PROGRAF problem was reported by a Physician from JAPAN on Oct 24, 2007. Female patient, 48 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, histiocytosis haematophagic, no therapeutic response, serum ferritin increased, . PROGRAF dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE. Patient died.
GRAFT VERSUS HOST DISEASE : Prograf Side Effects Report #5515363-3
Physician from UNITED STATES reported PROGRAF problem on Nov 02, 2007. Female patient, 55 years of age, was diagnosed with liver transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, pleural effusion, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, BACTRIM, ACTIGALL, BUMEX, PEPCID, FLEXERIL, NORCO. Patient was hospitalized. Patient died on 06/05/2007.
GRAFT VERSUS HOST DISEASE : Etoposide Side Effects Report #5523760-5
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on Nov 19, 2007. Male patient was diagnosed with graft versus host disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, squamous cell carcinoma, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, CYCLOSPORINE. Patient recovered.
GRAFT VERSUS HOST DISEASE : Cyclophosphamide Side Effects Report #5525211-3
Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Nov 19, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, squamous cell carcinoma, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, CYTARABINE, AZATHIOPRINE, PREDNISOLONE. Patient recovered.
GRAFT VERSUS HOST DISEASE : Prograf Side Effects Report #5525659-7
PROGRAF problem was reported by a Physician from UNITED STATES on Nov 12, 2007. Female patient, 16 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, herpes sepsis, herpes simplex, oral herpes, pancytopenia, pneumonia herpes viral, respiratory failure, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient died.
GRAFT VERSUS HOST DISEASE : Daunorubicin Side Effects Report #5533357-9
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN HYDROCHLORIDE problem on Nov 14, 2007. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with DAUNORUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, herpes virus infection, lip and/or oral cavity cancer, stem cell transplant, . DAUNORUBICIN HYDROCHLORIDE dosage: unknown. During the same period patient was treated with ETOPOSIDE, FLUDARABINE PHOSPHATE, CYTARABINE, CYCLOPHOSPHAMIDE, TACROLIMUS, MYCOPHENOLATE MOFETIL, METHOTREXATE. Patient recovered.
GRAFT VERSUS HOST DISEASE : Prograf Side Effects Report #5477633-7
PROGRAF problem was reported by a Physician from JAPAN on Sept 20, 2007. Male patient, 41 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, non-hodgkin's lymphoma recurrent, thrombotic microangiopathy, . PROGRAF dosage: 0.03 MG/LG, /D. During the same period patient was treated with METHOTREXATE, PREDNISONE, MYCOPHENOLATE MOFETIL. Patient recovered.
GRAFT VERSUS HOST DISEASE : Cyclophosphamide Side Effects Report #5484112-X
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Oct 02, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.
GRAFT VERSUS HOST DISEASE : Cyclophosphamide Side Effects Report #5484113-1
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.
GRAFT VERSUS HOST DISEASE : Fludara Side Effects Report #5484114-3
Physician from UNITED STATES reported FLUDARA problem on Oct 02, 2007. Female patient was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . FLUDARA dosage: 25 MG/M2 DAYS -6 TO -2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DONOR LYMPHOCYTE INFUSION. Patient was hospitalized. Patient died.
GRAFT VERSUS HOST DISEASE : Cyclophosphamide Side Effects Report #5484115-5
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.
GRAFT VERSUS HOST DISEASE : Cyclophosphamide Side Effects Report #5484116-7
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Oct 02, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.
GRAFT VERSUS HOST DISEASE : Rituximab Side Effects Report #5492595-4
RITUXIMAB problem was reported by a Physician from FRANCE on Jan 02, 2007. Male patient was diagnosed with chronic lymphocytic leukaemia, infection, cytomegalovirus infection and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . RITUXIMAB dosage: 375 MG, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, AMIKLIN, CYMEVAN. Patient was hospitalized. Patient recovered.
GRAFT VERSUS HOST DISEASE : Exjade Side Effects Report #5500941-8
Consumer or non-health professional from UNITED STATES reported EXJADE problem on Oct 25, 2007. Male patient was diagnosed with acute myeloid leukaemia and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, stem cell transplant, . EXJADE dosage: 3000 MG, QD. Patient died.
GRAFT VERSUS HOST DISEASE : Cyclophosphamide Side Effects Report #5458620-1
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from AUSTRIA on Sept 17, 2007. Male patient, 54 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, septic shock, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TRANSFUSION. Patient died.
GRAFT VERSUS HOST DISEASE : Cyclophosphamide Side Effects Report #5465810-0
Health Professional from AUSTRIA reported CYCLOPHOSPHAMIDE problem on Sept 21, 2007. Male patient, 54 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, septic shock, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TRANSFUSION. Patient died.
GRAFT VERSUS HOST DISEASE : Caspofungin Side Effects Report #5470935-X
CASPOFUNGIN MSD problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2007. Female patient, 63 years of age, was diagnosed with fungal infection and was treated with CASPOFUNGIN MSD. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, multi-organ failure, . CASPOFUNGIN MSD dosage: unknown. During the same period patient was treated with CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, VORICONAZOLE. Patient was hospitalized. Patient died.
GRAFT VERSUS HOST DISEASE : Cyclosporine Side Effects Report #5409312-6
Consumer or non-health professional from BRAZIL reported CYCLOSPORINE problem on July 26, 2007. Male patient, 67 years of age, was diagnosed with immunosuppression and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, kaposi's sarcoma, leukopenia, meningitis cryptococcal, nosocomial infection, pneumonia, pseudomembranous colitis, rash maculo-papular, respiratory failure, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS. Patient died.